EKF Diagnostics highlighted the new Stanbio Chemistry Glycated Albumin (GA) assay kit and its DiaSpect haemoglobin point-of-care (POC) analyser at the recent AACC 2018 Clinical Lab Expo in Chicago.
The Stanbio Chemistry GA assay uses an enzymatic method with liquid reagents and requires no preparation. It can be used on compatible open-channel clinical chemistry analysers and expresses results as a ratio of GA to albumin in mmol/mol from a small amount of serum. Glycated albumin accurately reflects the latest blood glucose status as it is found throughout the body and is a type of protein that can readily be glycated. Measurement of GA can confirm changes in blood glucose status one to two weeks after the commencement of treatment, as illustrated here.
DiaSpect is a hand-held and reagent-free system, ideally suited for use in the POC setting. The analyser’s simplicity of use means that it is suited to a range of settings and can be operated by various healthcare personnel with a minimal amount of training.
DiaSpect analyses whole blood from a sampling microcuvette that has been designed to collect a blood sample from any angle without forming air bubbles. This feature has the benefit of minimising the need for repeat testing. Laboratory quality haemoglobin results are delivered in about one second of the microcuvette being placed in the analyser.
